PROSTATE CANCER: Clinical hallmarks in whole cancer genomes

    loading  Checking for direct PDF access through Ovid

Abstract

Fraser and colleagues describe the whole-genome sequencing (WGS) profiles of over 200 localized intermediate-risk prostate cancers. WGS has been widely used in research but not, thus far, in clinical settings. Herein, we consider the possible use of WGS in the field of precision oncology.

Refers to Fraser, M. et al. Genomic hallmarks of localized, non-indolent prostate cancer. Nature541,359-364 (2017)

Related Topics

    loading  Loading Related Articles